eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | c syndrome |
| Comorbidity | C0011860|type 2 diabetes |
| Sentences | 72 |
| PubMedID- 22389088 | The metabolic syndrome is often associated with type 2 diabetes mellitus, dyslipidemia, atherosclerosis, hypertension, steatosis of the liver and other organs, as well as hypertension, type 2 diabetes mellitus, and atherosclerosis. |
| PubMedID- 24708638 | Our previous study showed that nc is a good predictor of metabolic syndrome in patients with type 2 diabetes [3]. |
| PubMedID- 21409896 | The objective of the study was to observe the frequency of metabolic syndrome (mets) in patients with type 2 diabetes mellitus and study the relationship of insulin resistance with the metabolic syndrome and its different clinical parameters. |
| PubMedID- 21498915 | type 2 diabetes mellitus (t2dm) associated with metabolic syndrome (mets) represents a high risk of cardiovascular disease. |
| PubMedID- 20966915 | Cd36 variants have been associated with type 2 diabetes, features of the metabolic syndrome, and alterations in lipid metabolism. |
| PubMedID- 20153706 | Conclusions: the prevalence of metabolic syndrome in patients with type 2 diabetes in spain is high, even when the low consistency among who, ncep-atp iii and idf criteria is considered. |
| PubMedID- 22650602 | Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-saharan africans. |
| PubMedID- 20197633 | Hs-crp was the highest in the metabolic syndrome patients with type 2 diabetes. |
| PubMedID- 20009096 | It is also apparent from the present study that children with top quintile (high risk) of glucose, insulin, and homa-ir levels displayed increased prevalence of metabolic syndrome and are associated with type 2 diabetes. |
| PubMedID- 22540858 | For the type 2 diabetes (t2d), signs of the metabolic syndrome with high risk for chronic micro- and macro-vascular complications are typical. |
| PubMedID- 21448316 | The risk factors for metabolic syndrome in type 2 diabetes mellitus patients are highly dependent on the criteria used to define the syndrome, supporting the need for a single clinically useful and epidemiologically useful definition. |
| PubMedID- 23707905 | These results demonstrate that sglt2 selective inhibitor ipragliflozin improves not only hyperglycemia but also diabetes/obesity-associated metabolic abnormalities in type 2 diabetic mice and suggest that ipragliflozin may be useful in treating type 2 diabetes with metabolic syndrome. |
| PubMedID- 20012885 | This study determines the prediction of low-risk lifestyle on type 2 diabetes in those with and without metabolic syndrome in a pooled sample of two representative finnish cohorts, collected in 1978-1980 and 2000-2001. |
| PubMedID- 20827436 | Our patient has a type 2 diabetes with metabolic syndrome defined by an increased waist/hip circumferences more than 0.9, a decreased hdl cholesterol less than 0.4 g/l and diabetes [15]. |
| PubMedID- 22723729 | Through these biological mechanisms, the administration of hanp exerted beneficial effects on experimental and clinical acute renal failure.2,3 contrary to these reports, anp was also reported to increase urinary albumin excretion in normoalbuminuric patients with type 1 and type 2 diabetes.15,16 in patients with nephrotic syndrome, plasma anp levels were significantly higher, and the elevated anp enhanced urinary protein excretion. |
| PubMedID- 21446088 | Conclusion: administration of metformin in type 2 diabetes with metabolic syndrome decreased cardiovascular risk factors by reducing glycemia, triglycerides, bmi, central obesity and insulin resistance. |
| PubMedID- 21055836 | Methods: 150 men were recruited from a genetic screening programme for hereditary hemocromatosis (hh) and were tested for type 2 diabetes, other components of the metabolic syndrome, beta cell function (bcf), insulin sensitivity, high-sensitivity c-reactive protein and iron overload. |
| PubMedID- 25782325 | [clinical evaluation of the influence of certain initial status parameters on the development of type 2 diabetes mellitus in patients with metabolic syndrome]. |
| PubMedID- 23611470 | Lunch energy density and the metabolic syndrome in patients with type 2 diabetes mellitus. |
| PubMedID- 25536005 | Hypovitaminosis d in type 2 diabetes: relation with features of the metabolic syndrome and glycemic control. |
| PubMedID- 24741576 | In the literature, it has been described that plasma il-6 levels are associated with increased cv risk and observed in sle patients with metabolic syndrome [53] and in patients with type 2 diabetes [44, 54]. |
| PubMedID- 21272190 | Aim: we examined the effects of the 11beta-hydroxysteroid dehydrogenase type 1 (hsd1) inhibitor, mk-0916, on the multiple components of the metabolic syndrome (mets) in patients with type 2 diabetes (t2dm) and mets. |
| PubMedID- 24589612 | Objective: to study the correlation between adipocytokines levels and metabolic syndrome (ms) in patients with newly diagnosed type 2 diabetes mellitus (t2dm). |
| PubMedID- 23250798 | Objective: to analyze the participation of fatty liver (fl) in the association of metabolic syndrome (ms) with type 2 diabetes and coronary artery calcification (cac). |
| PubMedID- 25648511 | Fibre is the largest component of the seaweed biomass [10,11] and therefore may be present in sufficient amounts when included in the diet to prevent metabolic syndrome associated with obesity, type 2 diabetes and cardiovascular complications [12]. |
| PubMedID- 22762010 | Serum levels of c-peptide are associated with the metabolic syndrome in patients with type 2 diabetes and in diabetic patients with nephropathy and vascular disease [37]. |
| PubMedID- 25054102 | Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 25657309 | Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. |
| PubMedID- 23913501 | It became important therefore to study the prevalence of metabolic syndrome in type 2 diabetes in lagos, nigeria as at the present time and compare it with previous prevalence rates as well as rates from other centres as a way of assessing current cardiovascular risk burden in this population. |
| PubMedID- 21089455 | [cardiac autonomous neuropathy and metabolic syndrome in patients with type 2 diabetes mellitus]. |
| PubMedID- 24695869 | Conclusions: this study established a strong association between low serum testosterone and metabolic syndrome in subjects with both type 2 diabetes and hypertension. |
| PubMedID- 21842146 | The primary etiology of the metabolic syndrome in type 2 diabetes is chronic overnutrition resulting in insulin resistance, abdominal obesity, hyperinsulinemia, and lipotoxicity. |
| PubMedID- 24072533 | In vitro studies using human aortic endothelial cells showed that ebselen abrogates h2o2‐induced increases in p‐ikk, p‐jnk, tumor necrosis factor–α, and nox2.24,46 in zucker diabetic fat rats, a model of type 2 diabetes associated with metabolic syndrome, ebselen prevented premature endothelial cell senescence and improved endothelial dysfunction (improved acetylcholine response).23 cellular antioxidant enzymes such as glutathione peroxidase 1 and superoxide dismutase have a central role in the control of reactive oxygen species. |
| PubMedID- 25435604 | Anti-hyperglycemic and anti-hyperlipidemic potential of a polyherbal preparation "diabegon" in metabolic syndrome subject with type 2 diabetes. |
| PubMedID- 22474593 | At present, little data exist about incidence and the risk factors associated with metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22075986 | More recently, jurg introduced the critical new concept of the metabolic inflammasome, which senses metabolic stress and contributes to the onset of the metabolic syndrome associated with obesity and type 2 diabetes. |
| PubMedID- 25572764 | The present study aimed to assess the metabolic syndrome in type 2 diabetes and compare them with two used methods of diagnostic criteria in gorgan. |
| PubMedID- 24103901 | Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. |
| PubMedID- 22187640 | In humans, a daily intake of at least 5 g of soluble fiber, particularly from whole-grain foods and fruits, reduced the presence of metabolic syndrome in patients with type 2 diabetes by 54% [65]. |
| PubMedID- 21315688 | Taken together, these results may provide evidence of the therapeutic potential of kr-66344, as a 11beta-hsd1 inhibitor, in obesity and type 2 diabetes patients with metabolic syndrome. |
| PubMedID- 19479185 | Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes. |
| PubMedID- 22644836 | type 2 diabetes is frequently associated with metabolic syndrome (mets). |
| PubMedID- 20398338 | The data presented indicate that the african grass rat (nile rat) represents a novel model of metabolic syndrome associated with diet-induced type 2 diabetes, expressing developmental growth and nutritional correlates similar to those in humans. |
| PubMedID- 21730222 | Objective: to investigate possible associations of dietary glycemic index (gi) and fiber content with metabolic syndrome (mets) in patients with type 2 diabetes. |
| PubMedID- 20823099 | Of significance in the zucker diabetic fat rat, a model of type 2 diabetes associated with the metabolic syndrome, ebselen improved endothelial dysfunction and renal insufficiency (21,22). |
| PubMedID- 24428913 | However, in regards to omentin-1, few studies have evaluated the relationship between omentin-1 and the metabolic syndrome in patients without concomitant type 2 diabetes and/or cardiovascular disease (termed “nascent metabolic syndrome” by jialal et al.) |
| PubMedID- 25550516 | These findings are important to consider in designing drugs to target type 2 diabetes and other features of the "metabolic syndrome." medical school, boston, ma 02115; school, boston, ma 02215; and. |
| PubMedID- 26221526 | Lower vegetable protein intake and higher dietary acid load associated with lower carbohydrate intake are risk factors for metabolic syndrome in patients with type 2 diabetes: post-hoc analysis of a cross-sectional study. |
| PubMedID- 24803311 | The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. |
| PubMedID- 24588601 | Association of serum uric acid and metabolic syndrome in type 2 diabetes. |
Page: 1 2